Combining delivery of siRNAs/miRNA mimics that inhibit the DARS1-AS1/YBX1 axis using nanoparticle platforms (66) with radiation or PARPi therapy may provide a new therapeutic strategy for treating GBM, which warrants further research. Here, DARS1 is linked to glioblastoma.